Epstein-Barr virus infection and the pathogenesis of nasopharyngeal carcinoma: Viral gene expression, tumour cell phenotype, and the role of the lymphoid stroma

Seminars in Cancer Biology

Volumn 7, Issue 4, 1996, Pages 165-174

  Niedobitek, Gerald ^a,b   Agathanggelou, Angelo ^a,b   Nicholls, John M ^a,b  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

EBV; Nasopharyngeal carcinoma; Pathogenesis

Indexed keywords

ARTICLE; EPSTEIN BARR VIRUS; HUMAN; HUMAN TISSUE; LYMPHOID CELL; NASOPHARYNX CARCINOMA; NONHUMAN; PATHOGENESIS; PHENOTYPE; STROMA; UNDIFFERENTIATED CARCINOMA; VIRUS GENE;

EID: 0030221501     PISSN: 1044579X     EISSN: None     Source Type: Journal    
DOI: 10.1006/scbi.1996.0023     Document Type: Article

References (92)

1. 1. Rickinson AB, Kieff E (1996) Epstein-Barr virus, in Fields Virology (Fields BN, Knipe DM, Howley PM, eds) pp 2397-2446. Lipincott-Raven Philadelphia
2. 2. Klein G (1979) The relationship of the virus to nasopharyngeal carcinoma, in The Epstein-Barr virus (Epstein MA, Achong BG, eds) pp 339-350. Springer, Berlin, Heidelberg, New York
3. 3. Wolf H, zur Hausen H, Becker V (1973) EB viral genomes in epithelial nasopharyngeal carcinoma cells. Nature (London) 244:245-247
4. 4. Klein G, Giovanella BC, Lindahl T, Fialkow PJ, Singh S, Stehlin JS (1974) Direct evidence for the presence of Epstein-Barr virus DNA and nuclear antigen in malignant epithelial cells from patients with poorly differentiated carcinoma of the nasopharynx. Proc Natl Acad Sci USA 71:4737-4741
5. 5. Shibata D, Weiss LM (1992) Epstein-Barr virus-associated gastric adenocarcinoma. Am J Pathol 140:769-774
6. 6. Shibata D, Tokunaga M, Uemura Y, Sato E, Tanaka S, Weiss LM (1991) Association of Epstein-Barr virus with undifferentiated gastric carcinoma with intense lymphoid infiltrate. Am J Pathol 139:469-474
7. 7. Rowlands DC, Ito M, Mangham DC, Reynolds G, Herbst H, Hallissey MT, Fielding JWL, Newbold KM, Jones EL, Young LS, Niedobitek G (1993) Epstein-Barr virus and carcinomas: rare association of the virus with gastric adenocarcinomas. Br J Cancer 68:1014-1019
8. 8. Miller G (1990) The switch between latency and replication of Epstein-Barr virus. J Infect Dis 161:833-844
9. 9. Cohen JI, Wang F, Mannick J, Kieff E (1989) Epstein-Barr virus nuclear protein 2 is a key determinant of lymphocyte transformation. Proc Natl Acad Sci USA 86:9558-9562
10. 10. Kaye KM, Izumi KM, Kieff E (1993) Epstein-Barr virus latent membrane protein 1 is essential for B-lymphocyte growth transformation. Proc Natl Acad Sci USA 90:9150-9154
11. 11. Tomkinson B, Robertson E, Kieff E (1993) Epstein-Barr virus nuclear proteins EBNA-3A and EBNA-3C are essential for B-lymphocyte growth transformation. J Virol 67:2014-2025
12. 12. Hammerschmidt W, Sugden B (1989) Genetic analysis of immortalizing functions of Epstein-Barr virus in human B lymphocytes. Nature 340:393-397
13. 13. Yates J, Warren N, Reisman D, Sugden B (1984) A cis-acting element from the Epstein-Barr virus genome that permits stable replication of recombinant plasmids in latently infected cells. Proc Natl Acad Sci USA 81:3806-3810
14. 14. Miller CL, Burkhardt AL, Lee JH, Stealey B, Longnecker R, Bolen JB, Kieff E (1995) Integral membrane protein 2 of Epstein-Barr virus regulates reactivation from latency through dominant negative effects on protein-tyrosine kinases. Immunity 2:155-166
15. 15. Miller CL, Lee JH, Kieff E, Longnecker R (1994) An integral membrane protein (LMP2) blocks reactivation of Epstein-Barr virus from latency following surface immunoglobulin cross-linking. Proc Natl Acad Sci USA 91:772-776
16. 16. Wang D, Leibowitz D, Wang F, Gregory C, Rickinson A, Larson R, Springer T, Kieff E (1988) Epstein-Barr virus latent infection membrane protein alters the human B-lymphocyte phenotype: deletion of the amino terminus abolishes activity. J Virol 62:4173-4184
17. 17. Wang E, Gregory CD, Sample C, Rowe M, Leibowitz D, Murray R, Rickinson AB, Kieff E (1990) Epstein-Barr virus latent membrane protein (LMP-1) and nuclear proteins 2 and 3C are effectors of phenotypic changes in B lymphocytes: EBNA2 and LMP-1 cooperatively induce CD23. J Virol 64:2309-2318
18. 18. Wang D, Liebowitz D, Kieff E (1985) An EBV membrane protein expressed in immortalized lymphocytes transforms established rodent cells. Cell 43:831-840
19. 19. Dawson CW, Rickinson AB, Young LS (1990) Epstein-Barr virus latent membrane protein inhibits human epithelial cell differentiation. Nature 344:777-780
20. 20. Fahraeus R, Rymo L, Rhim JS, Klein G (1990) Morphological transformation of human keratinocytes expressing the LMP gene of Epstein-Barr virus. Nature 345:447-449
21. 21. Niedobitek G, Fahraeus R, Herbst H, Latza U, Ferszt A, Klein G, Stein H (1992) The Epstein-Barr virus encoded membrane protein (LMP) induces phenotypic changes in epithelial cells. Virchows Archiv B Cell Pathol 62:55-59
22. 22. Mosialos G, Birkenbach M, Yalamanchili R, Van Arsdale T, Ware C, Kieff E (1995) The Epstein-Barr virus transforming protein LMP1 engages signaling proteins for the tumour necrosis factor receptor family. Cell 80:389-399
23. 23. Rowe M, Peng-Pilon M, Huen DS, Hardy R, Croom-Carter D, Lundgren E, Rickinson AB (1994) Upregulation of bcl-2 by the Epstein-Barr virus latent membrane protein LMP1: a B-cell specific response that is delayed relative to NF-kb activation and to induction of cell surface markers. J Virol 68:122-131
24. 24. Lung ML, Chang RS, Huang ML, Guo HY, Choy D, Sham J, Tsa SY, Cheng P, Ng MH (1990) Epstein-Barr virus genotypes associated with nasopharyngeal carcinoma in southern China. Virology 177:44-53
25. 25. Knecht H, Bachmann E, Brousset P, Sandvej K, Nadal D, Bachmann F, Odermatt BF, Delsol G, Pallesen G (1993) Deletions within the LMP1 oncogene of Epstein-Barr virus are clustered in Hodgkin's disease and identical to those observed in nasopharyngeal carcinoma. Blood 82:2937-2942
26. 26. Lung ML, Lam WP, Sham J, Choy D, Yong-Sheng Z, Guo H-Y, Ng MH (1991) Detection and prevalence of the 'f' variant of Epstein-Barr virus in Southern China. Virology 185:67-71
27. 27. Lung ML, Chang GC, Miller TR, Wara WM, Phillips TL (1994) Genotypic analysis of Epstein-Barr virus isolates associated with nasopharyngeal carcinoma in Chinese immigrants to the United States. Int J Cancer 59:743-746
28. 28. Bouzid M, Djennaoui D, Dubreuil J, Bouguermouh A, Ellouz D, Abdelwahab J, Decaussin G, Ooka T (1994) Epstein-Barr virus genotypes in NPC biopsies from North Africa. Int J Cancer 56:468-473
29. 29. Khanim F, Yao Q-Y, Niedobitek G, Sihota S, Rickinson AB, Young LS (1996) Analysis of Epstein-Barr virus gene polymorphisms in normal donors and in virus-associated tumors from different geographical locations. Blood, in press
30. 30. Hu LF, Zabarovsky ER, Chen F, Cao SL, Ernberg I, Klein G, Winberg G (1991) Isolation and sequencing of the Epstein-Barr virus BNLF-1 (LMP1) from Chinese nasopharyngeal carcinoma. J Gen Virol 72:2399-2409
31. 31. Chen ML, Tsai CN, Liang CL, Shu CH, Huang CR, Sulitzeanu D, Liu ST, Chang YS (1992) Cloning and characterization of the latent membrane protein (LMP) of a specific Epstein-Barr virus variant derived from nasopharyngeal carcinoma in the Taiwanese population. Oncogene 7:2131-2140
32. 32. Zheng X, Yuan F, Hu L-F, Chen F, Klein G, Christensson B (1994) Effect of B-lymphocyte-and NPC-derived EBV-LMP1 gene expression on in vitro growth and differentiation of human epithelial cells. Int J Cancer 57:747-753
33. 33. Li S-N, Chang Y-S, Liu S-T (1996) Effect of a 10-amino acid deletion on the oncogenic activity of latent membrane protein 1 of Epstein-Barr virus. Oncogene 12:2129-2135
34. 34. Trivedi P, Hu LF, Christensson B, Masucci MG, Klein G, Winberg G (1994) Epstein-Barr virus (EBV)-encoded membrane protein LMP1 from a nasopharyngeal carcinoma is non-immunogenic in a murine model system, in contrast to a B cell-derived homologue. Eur J Cancer 30A:84-88
35. 35. Knecht H, Bachmann E, Brousset P, Rothenberger S, Einsele H, Lestou VS, Delsol G, Bachmann F, Ambros PF, Odermatt BF (1995). Mutational hot spots within the carboxy terminal region of the LMP1 oncogene of Epstein-Barr virus are frequent in lymphoproliferative disorders. Oncogene 10:523-528
36. 36. Tosato G, Magrath I, Koski I, Dooley N, Blaese M (1979) Activation of suppressor T cells during Epstein-Barr-virus-induced infectious mononucleosis. N Engl J Med 201:1133-1137
37. 37. Niedobitek G, Young LS (1994) Epstein-Barr virus persistence and virus-associated tumours. Lancet 343:333-335
38. 38. Allday MJ, Crawford DH (1988) Role of epithelium in EBV persistence and pathogenesis of B-cell tumours. Lancet i:855-857
39. 39. Sixbey JW, Nedrud JG, Raab-Traub N, Hanes RA, Pagano JS (1984) Epstein-Barr virus replication in oropharyngeal epithelial cells. N Engl J Med 310:1225-1230
40. 40. Sixbey JW, Davis DS, Young LS, Hutt-Fletcher L, Tedder TF, Rickinson AB (1987) Human epithelial-cell expression of an Epstein-Barr virus receptor. J Gen Virol 68:805-811
41. 41. Greenspan JS, Greenspan D, Lennette ET, Abrams DI, Canant MA, Petersen V, Freese UK (1985) Replication of Epstein-Barr virus within the epithelial cells of oral hairy leukoplakia, an AIDS-associated lesion. N Engl J Med 313:1564-1571
42. 42. Thomas JA, Felix DH, Wray D, Southam JC, Cubie HA, Crawford DH (1991) Epstein-Barr virus gene expression and epithelial cell differentiation in oral hairy leukoplakia. Am J Pathol 139:1369-1380
43. 43. Niedobitek G, Young LS, Lau R, Brooks L, Greenspan D, Greenspan JS, Rickinson AB (1991) Epstein-Barr virus infection in oral hairy leukoplakia: virus replication in the absence of a detectable latent phase. J Gen Virol 72:3035-3046
44. 44. Gilligan K, Rajadurai P, Resnick L, Raab-Traub N (1990) Epstein-Barr virus small nuclear RNAs are not expressed in permissively infected cells in AIDS-associated leukoplakia. Proceedings of the National Academy of Sciences USA 87:8790-8794
45. 45. Sandvej K, Krenacs L, Hamilton-Dutoit SJ, Rindum JL, Pindborg JJ, Pallesen G (1992) Epstein-Barr virus latent and replicative gene expression in oral hairy leukoplakia. Histopathology 20:387-395
46. 46. Nicholls JM (1996) Nasopharyngeal carcinoma: classification and histological appearances. Adv Anat Pathol, in press
47. 47. Niedobitek G, Hansmann ML, Herbst H, Young LS, Dienemann D, Hartmann CA, Finn T, Pitteroff S, Welt A, Anagnostopoulos I, Friedrich R, Lobeck H, Sam CK, Araujo I, Richinson AB, Stein H (1991) Epstein-Barr virus and carcinomas: undifferentiated carcinomas but not squamous cell carcinomas of the nasopharynx are regularly associated with the virus. J Pathol 165:17-24
48. 48. Niedobitek G, Young LS, Sam CK, Brooks L, Prasad U, Rickinson AB (1992) Expression of Epstein-Barr virus genes and of lymphocyte activation molecules in undifferentiated nasopharyngeal carcinomas. Am J Pathol 140:879-887
49. 49. Weiss LM, Movahed LA, Butler AE, Swanson SA, Frierson HF, Cooper PH, Colby TV, Mills SE (1989) Analysis of lymphoepithelioma and lymphoepithelioma-like carcinomas for Epstein-Barr virus by in situ hybridization. Am J Surg Pathol 13:625-631
50. 50. Raab-Traub N, Flynn K (1986) The structure of the termini of the Epstein-Barr virus as a marker of clonal cellular proliferation. Cell 47:883-889
51. 51. Henle W, Henle G, Ho H-C, Burtin P, Cachin Y, Clifford P, de Schryver A, de-The G, Diehl V, Klein G (1970) Antibodies to Epstein-Barr virus in nasopharyngeal carcinoma, other head and neck neoplasms, and control groups. J Natl Cancer Inst 44:225-231
52. 52. Micheau C (1986) What's new in histological classification and recognition of nasopharyngeal carcinoma (N.P.C.). Path Res Pract 181:249-253
53. 53. Niedobitek G, Agathanggelou A, Barber P, Smallman LA, Jones EL, Young LS (1993) p53 overexpression and Epstein-Barr virus infection in undifferentiated and squamous cell nasopharyngeal carcinomas. J Pathol 170:457-461
54. 54. Hording U, Winther Nielsen H, Daugaard S, Albeck H (1994) Human papillomavirus type 11 and 16 detected in nasopharyngeal carcinomas by the polymerase chain reaction. Laryngoscope 104:99-102
55. 55. Raab-Traub N, Flynn K, Pearson G, Huang A, Levine P, Lanier A, Pagano J (1987) The differentiated form of nasopharyngeal carcinoma contains Epstein-Barr virus DNA. Int J Cancer 39:25-29
56. 56. Pathmanathan R, Prasad U, Chandrika G, Sadler R, Flynn K, Raab-Traub N (1995) Undifferentiated, non-keratinising, and squamous cell carcinoma of the nasopharynx. Variants of Epstein-Barr virus-infected neoplasia. Am J Pathol 146:1355-1367
57. 57. Young LS, Dawson CW, Brown KW, Rickinson AB (1989) Identification of a human epithelial cell surface protein sharing an epitope with the C3d/ Epstein-Barr virus receptor molecule of B lymphocytes. Int J Cancer 43:786-794
58. 58. Niedobitek G, Herbst H, Stein H (1989) Epstein-Barr virus/ complement receptor and epithelial cells. Lancet II:110
59. 59. Birkenbach M, Tong X, Bradbury LE, Tedder TF, Kieff E (1992) Characterization of an Epstein-Barr virus receptor on human epithelial cells. J Exp Med 176:1405-1414
60. 60. Knox PG, Li Q-X, Rickinson AB, Young LS (1996) In vitro production of stable Epstein-Barr virus-positive epithelial cell clones which resemble the virus: cell interaction observed in nasopharyngeal carcinoma. Virology 215:40-50
61. 61. Li QX, Young LS, Niedobitek G, Dawson CW, Birkenbach M, Wang F, Rickinson AB (1992) Epstein-Barr virus infection and replication in a human epithelial cell system. Nature 356:347-350
62. 62. Sixbey JW, Yao QY (1992) Immunoglobulin A-induced shift of Epstein-Barr virus tissue tropism. Science 225:1578-1580
63. 63. Sam CK, Brooks LA, Niedobitek G, Young LS, Prasad U, Rickinson AB (1993) Analysis of Epstein-Barr virus infection in nasopharyngeal biopsies from a group at high risk of nasopharyngeal carcinoma. Int J Cancer 53:957-962
64. 64. Pathmanathan R, Prasad U, Sadler R, Flynn K, Raab-Traub N (1995) Clonal proliferations of cells infected with Epstein-Barr virus in preinvasive lesions related to nasopharyngeal carcinoma. N Engl J Med 333:693-698
65. 65. Kieff E (1995) Epstein-Barr virus-increasing evidence of a link to carcinoma. N Engl J Med 333:724-726
66. 66. Murray PG, Niedobitek G, Kremmer E, Grasser F, Reynolds GM, Cruchley A, Williams DM, Muller-Lantzsch N, Young LS (1996) In situ detection of the Epstein-Barr virus-encoded nuclear antigen 1 in oral hairy leukoplakia and virus-associated carcinomas. J Pathol 178:44-47
67. 67. Fahraeus R, Li-Fu H, Ernberg I, Finke J, Rowe M, Klein G, Falk K, Nilsson E, Yadaf M, Busson P, Tursz T, Kallin B (1988) Expression of Epstein-Barr virus-encoded proteins in nasopharyngeal carcinoma. Int J Cancer 42:329-338
68. 68. Young L, Dawson C, Clark D, Rupani H, Busson P, Tursz T, Johnson A, Rickinson A (1988) Epstein-Barr virus gene expression in nasopharyngeal carcinoma. J Gen Virol 69:1051-1065
69. 69. Brooks LA, Lear AL, Young LS, Rickinson AB (1993) Transcripts from the Epstein-Barr virus BamHI A fragment are detectable in all three forms of virus latency. J Virol 67:3182-3190
70. 70. Gilligan KJ, Rajadurai P, Lin J-C, Busson P, Abdel-Hamid M, Prasad U, Tursz T, Raab-Traub N (1991) Expression of the Epstein-Barr virus BamHI A fragment in nasopharyngeal carcinoma: evidence for a viral protein expressed in vivo. J Virol 65:6252-6259
71. 71. Cochet C, Martel-Renoir D, Grunewald V, Bosq J, Cochet G, Schwaab G, Bernaudin J-F, Joab I (1993) Expression of the Epstein-Barr virus immediate early gene, BZLF1, in nasopharyngeal carcinoma tumor cells. Virology 197:358-365
72. 72. Martel-Renoir D, Grunewald V, Touitou R, Schwaab G, Joab I (1995) Qualitative analysis of the expression of Epstein-Barr virus lytic genes in nasopharyngeal carcinoma biopsies. J Gen Virol 76:1401-1408
73. 73. Henle G, Henle W (1976) Epstein-Barr virus-specific IgA serum antibodies as an outstanding feature of nasopharyngeal carcinoma. Int J Cancer 17:1-7
74. 74. Agathanggelou A, Niedobitek G, Chen R, Nicholls J, Yin W, Young LS (1995) Expression of immune regulatory molecules in Epstein-Barr virus-associated nasopharyngeal carcinomas with prominent lymphoid stroma. Evidence for a functional interaction between epithelial tumor cells and infiltrating lymphoid cells. Am J Pathol 147:1152-1160
75. 75. Walter J, Schirrmacher V, Mosier D (1995) Induction of CD44 expression by the Epstein-Barr virus latent membrane protein LMP1 is associated with lymphoma dissemination. Int J Cancer 61:363-369
76. 76. Brooks L, Niedobitek G, Agathanggelou A, Farrell PJ (1995) The expression of variant CD44 in nasopharyngeal carcinoma is unrelated to expression of LMP-1. AM J Pathol 146:1102-1112
77. 77. Yokochi T, Holly RD, Clark EA (1982) B lymphoblast antigen (BB-1) expressed on Epstein-Barr virus-activated B cell blasts, B lymphoblastoid cell lines, and Burkitt's lymphomas. J Immunol 128:823-827
78. 78. Gruss HJ, Hirschstein D, Wright B, Ulrich D, Caligiuri MA, Barcos M, Strockbine L, Armitage RJ, Dower SK (1994) Expression and function of CD40 on Hodgkin and Reed-Sternberg cells and the possible relevance for Hodgkin's disease. Blood 84:2305-2314
79. 79. Mahe Y, Hirose K, Clausse B, Chouaib S, Tursz T, Mariame B (1992) Heterogeneity among human nasopharyngeal carcinoma cell lines for inflammatory cytokines mRNA expression levels. Biochem Biophys Res Commun 187:121-126
80. 80. Busson P, Braham K, Ganem G, Thomas F, Grausz D, Lipinski M, Wakasugi H, Tursz T (1987) EBV containing epithelial cells from nasopharyngeal carcinoma produce IL-1 alpha. Proc Natl Acad Sci USA 84:6262-6266
81. 81. Hintzen RQ, Lens SMA, Koopman G, Pals ST, Spits H, van Lier RAW (1994) CD70 represents the human ligand for CD27. Int Immunol 6:477-480
82. 82. Hintzen RQ, de Jong R, Lens SMA, van Lier RAW (1994) CD27: marker and mediator of T-cell activation? Immunol Today 15:307-311
83. 83. Dorken B, Moller P, Pezzutto A, Schwartz-Albiez R, Moldenhauer G (1989) B cell antigens: CD40, in Leukocyte Typing IV (Knapp W, Dorken B, Gilks WR, Rieber EP, Schmidt RE, Stein H, von dem Borne AEGK, eds) pp 90-91. Oxford University Press, Oxford.
84. 84. Ledbetter JA, Shu G, Gallagher M, Clark EA (1987) Augmentation of normal and malignant B cell proliferation by monoclonal antibody to the B cell specific antigen BP50 (CDw40). J Immunol 138:788-794
85. 85. Lederman S, Yellin MJ, Cleary AM, Pernis A, Inghirami G, Cohn LE, Covey LR, Lee JJ, Rothman P, Chess L (1994) T-BAM/ CD40-L on helper T lymphocytes augments lymphokine-induced B cell Ig isotype switch recombination and rescuesB cells from programmed cell death. J Immunol 152:2163-2171
86. 86. Holder MJ, Wang H, Milner AE, Casamayor M, Armitage R, Spriggs MK, Fanslow WC, MacLennan ICM, Gregory CD, Gordon J (1993) Suppression of apoptosis in normal and neoplastic human B lymphocytes by CD40 ligand is independent of Bcl-2 induction. Eur J Immunol 23:2368-2371
87. 87. Lu Q-L, Elia G, Lucas S, Thomas JA (1993) Bcl-2 proto-oncogene expression in Epstein-Barr virus-associated nasopharyngeal carcinoma. Int J Cancer 53:29-35
88. 88. Engel P, Gribben JG, Greeman GJ, Zhou LJ, Nozawa Y, Abe M, Nadler LM, Wakasa H, Tedder TF (1994) The B7-2 (B70) costimulatory molecule expressed by monocytes and activated B lymphocytes is the CD86 differentiation antigen. Blood 84:1402-1407
89. 89. June CH, Bluestone JA, Nadler LM, Thompson CB (1994) The B7 and CD28 receptor families. Immunol Today 15:321-331
90. 90. Ramarathinam L, Castle M, Wu Y, Liu Y (1994) T cell costimulation by B7/ BB1 induces T cell-dependent tumor rejection: an important role of B7/ BB1 in the induction, recruitment, and effector function of antitumor T cells, J Exp Med 179:1205-1214
91. 91. Hu L-F, Chen F, Zhen Q-F, Zhang Y-W, Luo Y, Zheng X, Winberg G, Ernberg I, Klein G (1995) Differences in the growth pattern and clinical course of EBV-LMP1 expressing and non-expressing nasopharyngeal carcinomas. Eur J Cancer 31A:658-660
92. 92. Rucco LP, Stoppacciaro A, Uccini S, Breviario F, Dejana E, Gallo A, De Vincentiis M, Pileri S, Nicholls JM, Baroni CD (1994) Expression of intercellular adhesion molecule-1 and vascular cell adhesion molecule-1 in undifferentiated nasopharyngeal carcinoma (lymphoepithelioma) and in malignant epithelial tumours. Hum Pathol 25:924-928